Katsuki Hirai

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016)

Osamu Nishida, Hiroshi Ogura, Moritoki Egi et al. · Journal of Intensive Care · 2018 · 108 citations · Full text

Veterinary Medicine, Internal Medicine, Perioperative Critical Care +15

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J‐<scp>SSCG</scp>2016)

Osamu Nishida, Hiroshi Ogura, Moritoki Egi et al. · Acute Medicine & Surgery · 2018 · 79 citations · Full text

Medicine, Internal Medicine, Critical Care Medicine +16

Biotin-responsive basal ganglia disease: a case diagnosed by whole exome sequencing

Kensaku Kohrogi, Eri Imagawa, Yuichiro Muto et al. · Journal of Human Genetics · 2015 · 28 citations · Full text

Life Sciences, Neurology, Neuroscience +11

Survey of pediatric ward hospitalization due to respiratory syncytial virus infection after the introduction of palivizumab to high‐risk infants in Japan

Satoshi Kusuda, Naoto Takahashi, Takami Saitoh et al. · Pediatrics International · 2010 · 18 citations

Public Health, Infectious Diseases, Pediatrics +15